Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ASCEND: Vagus Nerve Stimulation Titration Protocol to Improve Tolerance and Accelerate Adaptation

NCT02385526 is registered in ClinicalTrials.gov with Cyberonics, Inc. as lead sponsor.

NCT NCT02385526
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02385526 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ASCEND: Vagus Nerve Stimulation Titration Protocol to Improve Tolerance and Accelerate Adaptation
Lead sponsor
Cyberonics, Inc.
Phase
Observational
Overall status
Completed
Start date
April 28, 2015
Completion date
October 10, 2016
Enrollment
67 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

epilepsy, seizures